Thursday, 13 February 2020

S&P reaffirms India rating at 'BBB-' | Long-time India bull turns bearish | AIF investments surge in Q3

To keep you updated, we send ET Markets Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

DAILY BRIEF

Thu, Feb 13, 2020

#Budget#StockScreener#Earnings#ExpertViews#StockRecos
TOP OF THE DAY
S&P reaffirms India rating at 'BBB-' with stable outlook
S&P expects that the economy will continue to outperform peers at a similar level of income.
Nifty50 forms a small bearish candle, but support stays intact
India bull turns cautious as political rifts threaten growth
Rally in this stock enters 5th year. Can it still be a buy?
SBI MF lapped up blue chips in Jan; plays big on these sectors
AIF investment rises to Rs 1.4 lakh crore in December quarter
IRCTC, YES, Granules India rally; 66 stocks flash 'buy' signal

Top Gainers

NSE
5 companies (largecap) appreciated more than 3%
Trent 4.13%
Dr. Reddys Laborat 4.03%
More from Gainers

Top Losers

NSE
8 companies (largecap) price decreased more than -3%
IGL -4.81%
NMDC -4.06%
More from Losers

52 Week High

NSE
70 companies touched new 52-week high today
Indian Railway Catering & Tourism Corporation Ltd. 11.67%
Tasty Bite Eat 11.29%
More from 52 Week High
AdvertorialThis one change can boost up your business
Advertorial7 point guide to choose a Term Insurance based on Claim Settlement records
Inflation seen peaking, opens room for RBI rate cuts
​ Data showed retail inflation surged to 7.6 per cent last month from a year earlier.
View: Look at ELSS as a regular equity investing opportunity
F&O: Declines are getting bought into, but followup buying missing
Don't be adventurous, stick to top 1-2 players: Vikas Khemani
RECOMMENDATIONS
ICICI Bank Ltd. Buy
Eicher Motors Ltd. Buy
Kotak Mahindra Bank Ltd. Buy
Tata Consumer Products Ltd. Buy
Jubilant Foodworks Ltd. Buy
Hemang Jani is bullish on UPL, Trent and ABFRL. Here's why
Given the overall slowdown in the economy and the corporate sector, pathology labs sector is emerging as a spa...
VIP chairman sees opportunity in coronavirus crisis; here's why
View: In the Coronavirus era, 'we don't know' is defensible
Expect good run-up in Trent, value buying in pharma: Elara Capital
Quick Links
Markets Live | Market Stats | IPOs | Technicals | Commodities | Forex
Follow Us:
Download ET Markets App:

No comments:

Post a Comment